Methacolamine has maximum agonists action at which of the following cholinergic receptors

**Core Concept**
Methacholine is a synthetic cholinergic agonist used in pharmacological testing to assess airway responsiveness. It acts on muscarinic acetylcholine receptors (mAChRs) in the airway smooth muscle. The type of mAChR that methacholine primarily interacts with determines its agonistic effect.

**Why the Correct Answer is Right**
Methacholine has a maximum agonistic action at M3 muscarinic receptors, which are the most abundant subtype of mAChRs in the airway smooth muscle. Activation of M3 receptors by methacholine leads to an increase in intracellular calcium levels, causing airway smooth muscle contraction and bronchoconstriction. This makes methacholine a useful agent for diagnosing and assessing the severity of asthma and other airway diseases.

**Why Each Wrong Option is Incorrect**
* **Option A:** M1 muscarinic receptors are primarily found in the central nervous system and are involved in regulating the release of neurotransmitters. Methacholine does not have a significant agonistic effect on M1 receptors.
* **Option B:** M2 muscarinic receptors are predominantly found in the heart and are involved in regulating heart rate and contraction. Methacholine does not have a significant agonistic effect on M2 receptors.
* **Option C:** M4 muscarinic receptors are found in the smooth muscle of the gastrointestinal tract and are involved in regulating gut motility. While methacholine can cause smooth muscle contraction, its primary action is not at M4 receptors.

**Clinical Pearl / High-Yield Fact**
Methacholine challenge testing is a useful diagnostic tool for assessing airway responsiveness and diagnosing asthma. It is particularly useful in patients with a history of asthma-like symptoms but normal spirometry results. A positive methacholine challenge test indicates an abnormal airway response to methacholine, which is a hallmark of asthma.

**Correct Answer:** M3. Methacholine has maximum agonistic action at M3 muscarinic receptors.